nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—SLCO1A2—Chlorambucil—testicular cancer	0.239	0.324	CbGbCtD
Sumatriptan—ABCG2—Dactinomycin—testicular cancer	0.0862	0.117	CbGbCtD
Sumatriptan—ABCG2—Carboplatin—testicular cancer	0.0579	0.0783	CbGbCtD
Sumatriptan—ABCG2—Cisplatin—testicular cancer	0.0495	0.0669	CbGbCtD
Sumatriptan—ABCG2—Etoposide—testicular cancer	0.0486	0.0657	CbGbCtD
Sumatriptan—SLCO1A2—Methotrexate—testicular cancer	0.0429	0.058	CbGbCtD
Sumatriptan—SLCO1B1—Methotrexate—testicular cancer	0.0405	0.0547	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—testicular cancer	0.0332	0.0448	CbGbCtD
Sumatriptan—ABCG2—Methotrexate—testicular cancer	0.0321	0.0434	CbGbCtD
Sumatriptan—ABCB1—Dactinomycin—testicular cancer	0.0311	0.042	CbGbCtD
Sumatriptan—ABCB1—Vinblastine—testicular cancer	0.0195	0.0263	CbGbCtD
Sumatriptan—ABCB1—Cisplatin—testicular cancer	0.0178	0.0241	CbGbCtD
Sumatriptan—ABCB1—Etoposide—testicular cancer	0.0175	0.0237	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—testicular cancer	0.012	0.0162	CbGbCtD
Sumatriptan—ABCB1—Methotrexate—testicular cancer	0.0116	0.0157	CbGbCtD
Sumatriptan—Bronchitis—Doxorubicin—testicular cancer	0.000139	0.000535	CcSEcCtD
Sumatriptan—Rash—Dactinomycin—testicular cancer	0.000138	0.000531	CcSEcCtD
Sumatriptan—Decreased appetite—Etoposide—testicular cancer	0.000138	0.00053	CcSEcCtD
Sumatriptan—Diarrhoea—Ifosfamide—testicular cancer	0.000137	0.000528	CcSEcCtD
Sumatriptan—Pancytopenia—Doxorubicin—testicular cancer	0.000137	0.000528	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Etoposide—testicular cancer	0.000137	0.000526	CcSEcCtD
Sumatriptan—Body temperature increased—Cisplatin—testicular cancer	0.000137	0.000526	CcSEcCtD
Sumatriptan—Fatigue—Etoposide—testicular cancer	0.000137	0.000525	CcSEcCtD
Sumatriptan—Pain—Etoposide—testicular cancer	0.000136	0.000521	CcSEcCtD
Sumatriptan—Constipation—Etoposide—testicular cancer	0.000136	0.000521	CcSEcCtD
Sumatriptan—Conjunctivitis—Epirubicin—testicular cancer	0.000135	0.000521	CcSEcCtD
Sumatriptan—Dysuria—Doxorubicin—testicular cancer	0.000135	0.00052	CcSEcCtD
Sumatriptan—Haemoglobin—Methotrexate—testicular cancer	0.000134	0.000516	CcSEcCtD
Sumatriptan—Haemorrhage—Methotrexate—testicular cancer	0.000134	0.000514	CcSEcCtD
Sumatriptan—Sweating—Epirubicin—testicular cancer	0.000134	0.000514	CcSEcCtD
Sumatriptan—Pollakiuria—Doxorubicin—testicular cancer	0.000134	0.000514	CcSEcCtD
Sumatriptan—Haematuria—Epirubicin—testicular cancer	0.000133	0.000511	CcSEcCtD
Sumatriptan—Dizziness—Ifosfamide—testicular cancer	0.000133	0.00051	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000132	0.000507	CcSEcCtD
Sumatriptan—Weight increased—Doxorubicin—testicular cancer	0.000132	0.000506	CcSEcCtD
Sumatriptan—Epistaxis—Epirubicin—testicular cancer	0.000131	0.000505	CcSEcCtD
Sumatriptan—Weight decreased—Doxorubicin—testicular cancer	0.000131	0.000503	CcSEcCtD
Sumatriptan—Sinusitis—Epirubicin—testicular cancer	0.000131	0.000503	CcSEcCtD
Sumatriptan—Feeling abnormal—Etoposide—testicular cancer	0.000131	0.000502	CcSEcCtD
Sumatriptan—Hyperglycaemia—Doxorubicin—testicular cancer	0.00013	0.000501	CcSEcCtD
Sumatriptan—Nausea—Dactinomycin—testicular cancer	0.00013	0.0005	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Etoposide—testicular cancer	0.00013	0.000498	CcSEcCtD
Sumatriptan—Drowsiness—Doxorubicin—testicular cancer	0.000129	0.000496	CcSEcCtD
Sumatriptan—Visual impairment—Methotrexate—testicular cancer	0.000129	0.000495	CcSEcCtD
Sumatriptan—Vomiting—Ifosfamide—testicular cancer	0.000128	0.000491	CcSEcCtD
Sumatriptan—Hypersensitivity—Cisplatin—testicular cancer	0.000128	0.00049	CcSEcCtD
Sumatriptan—Bradycardia—Epirubicin—testicular cancer	0.000127	0.00049	CcSEcCtD
Sumatriptan—Rash—Ifosfamide—testicular cancer	0.000127	0.000487	CcSEcCtD
Sumatriptan—Dermatitis—Ifosfamide—testicular cancer	0.000126	0.000486	CcSEcCtD
Sumatriptan—Urticaria—Etoposide—testicular cancer	0.000126	0.000484	CcSEcCtD
Sumatriptan—Haemoglobin—Epirubicin—testicular cancer	0.000126	0.000483	CcSEcCtD
Sumatriptan—Abdominal pain—Etoposide—testicular cancer	0.000125	0.000482	CcSEcCtD
Sumatriptan—Body temperature increased—Etoposide—testicular cancer	0.000125	0.000482	CcSEcCtD
Sumatriptan—Conjunctivitis—Doxorubicin—testicular cancer	0.000125	0.000482	CcSEcCtD
Sumatriptan—Haemorrhage—Epirubicin—testicular cancer	0.000125	0.000481	CcSEcCtD
Sumatriptan—Eye disorder—Methotrexate—testicular cancer	0.000125	0.00048	CcSEcCtD
Sumatriptan—Tinnitus—Methotrexate—testicular cancer	0.000125	0.000479	CcSEcCtD
Sumatriptan—Hypoaesthesia—Epirubicin—testicular cancer	0.000124	0.000478	CcSEcCtD
Sumatriptan—Asthenia—Cisplatin—testicular cancer	0.000124	0.000477	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—testicular cancer	0.000124	0.000475	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—testicular cancer	0.000123	0.000473	CcSEcCtD
Sumatriptan—Connective tissue disorder—Epirubicin—testicular cancer	0.000123	0.000473	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—testicular cancer	0.000122	0.000467	CcSEcCtD
Sumatriptan—Angiopathy—Methotrexate—testicular cancer	0.000121	0.000466	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—testicular cancer	0.000121	0.000465	CcSEcCtD
Sumatriptan—Immune system disorder—Methotrexate—testicular cancer	0.000121	0.000464	CcSEcCtD
Sumatriptan—Visual impairment—Epirubicin—testicular cancer	0.000121	0.000463	CcSEcCtD
Sumatriptan—Mediastinal disorder—Methotrexate—testicular cancer	0.00012	0.000463	CcSEcCtD
Sumatriptan—Chills—Methotrexate—testicular cancer	0.00012	0.000461	CcSEcCtD
Sumatriptan—Nausea—Ifosfamide—testicular cancer	0.000119	0.000458	CcSEcCtD
Sumatriptan—Diarrhoea—Cisplatin—testicular cancer	0.000118	0.000455	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—testicular cancer	0.000118	0.000453	CcSEcCtD
Sumatriptan—Eye disorder—Epirubicin—testicular cancer	0.000117	0.000449	CcSEcCtD
Sumatriptan—Hypersensitivity—Etoposide—testicular cancer	0.000117	0.000449	CcSEcCtD
Sumatriptan—Tinnitus—Epirubicin—testicular cancer	0.000117	0.000448	CcSEcCtD
Sumatriptan—Erythema—Methotrexate—testicular cancer	0.000116	0.000447	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—testicular cancer	0.000116	0.000447	CcSEcCtD
Sumatriptan—Flushing—Epirubicin—testicular cancer	0.000116	0.000446	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—testicular cancer	0.000116	0.000445	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—testicular cancer	0.000115	0.000443	CcSEcCtD
Sumatriptan—Dysgeusia—Methotrexate—testicular cancer	0.000114	0.000438	CcSEcCtD
Sumatriptan—Asthenia—Etoposide—testicular cancer	0.000114	0.000437	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—testicular cancer	0.000114	0.000437	CcSEcCtD
Sumatriptan—Angiopathy—Epirubicin—testicular cancer	0.000114	0.000436	CcSEcCtD
Sumatriptan—Immune system disorder—Epirubicin—testicular cancer	0.000113	0.000434	CcSEcCtD
Sumatriptan—Mediastinal disorder—Epirubicin—testicular cancer	0.000113	0.000433	CcSEcCtD
Sumatriptan—Back pain—Methotrexate—testicular cancer	0.000113	0.000433	CcSEcCtD
Sumatriptan—Chills—Epirubicin—testicular cancer	0.000112	0.000431	CcSEcCtD
Sumatriptan—Pruritus—Etoposide—testicular cancer	0.000112	0.000431	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—testicular cancer	0.000112	0.00043	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—testicular cancer	0.000112	0.000429	CcSEcCtD
Sumatriptan—Vomiting—Cisplatin—testicular cancer	0.00011	0.000423	CcSEcCtD
Sumatriptan—Rash—Cisplatin—testicular cancer	0.000109	0.000419	CcSEcCtD
Sumatriptan—Dermatitis—Cisplatin—testicular cancer	0.000109	0.000419	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—testicular cancer	0.000109	0.000419	CcSEcCtD
Sumatriptan—Diarrhoea—Etoposide—testicular cancer	0.000109	0.000417	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—testicular cancer	0.000108	0.000416	CcSEcCtD
Sumatriptan—Ill-defined disorder—Methotrexate—testicular cancer	0.000108	0.000415	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—testicular cancer	0.000108	0.000415	CcSEcCtD
Sumatriptan—Anaemia—Methotrexate—testicular cancer	0.000108	0.000413	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—testicular cancer	0.000107	0.000413	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—testicular cancer	0.000107	0.000412	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—testicular cancer	0.000107	0.00041	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—testicular cancer	0.000105	0.000405	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—testicular cancer	0.000105	0.000404	CcSEcCtD
Sumatriptan—Malaise—Methotrexate—testicular cancer	0.000105	0.000403	CcSEcCtD
Sumatriptan—Dizziness—Etoposide—testicular cancer	0.000105	0.000403	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—testicular cancer	0.000105	0.000402	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—testicular cancer	0.000105	0.000402	CcSEcCtD
Sumatriptan—Vertigo—Methotrexate—testicular cancer	0.000105	0.000402	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—testicular cancer	0.000104	0.000401	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—testicular cancer	0.000104	0.000399	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—testicular cancer	0.000103	0.000397	CcSEcCtD
Sumatriptan—Nausea—Cisplatin—testicular cancer	0.000103	0.000395	CcSEcCtD
Sumatriptan—Cough—Methotrexate—testicular cancer	0.000102	0.00039	CcSEcCtD
Sumatriptan—Ill-defined disorder—Epirubicin—testicular cancer	0.000101	0.000388	CcSEcCtD
Sumatriptan—Convulsion—Methotrexate—testicular cancer	0.000101	0.000388	CcSEcCtD
Sumatriptan—Vomiting—Etoposide—testicular cancer	0.000101	0.000388	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—testicular cancer	0.000101	0.000387	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—testicular cancer	0.000101	0.000387	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—testicular cancer	0.0001	0.000385	CcSEcCtD
Sumatriptan—Rash—Etoposide—testicular cancer	0.0001	0.000384	CcSEcCtD
Sumatriptan—Dermatitis—Etoposide—testicular cancer	9.99e-05	0.000384	CcSEcCtD
Sumatriptan—Headache—Etoposide—testicular cancer	9.93e-05	0.000382	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—testicular cancer	9.93e-05	0.000382	CcSEcCtD
Sumatriptan—Arthralgia—Methotrexate—testicular cancer	9.91e-05	0.000381	CcSEcCtD
Sumatriptan—Chest pain—Methotrexate—testicular cancer	9.91e-05	0.000381	CcSEcCtD
Sumatriptan—Myalgia—Methotrexate—testicular cancer	9.91e-05	0.000381	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—testicular cancer	9.87e-05	0.000379	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—testicular cancer	9.82e-05	0.000377	CcSEcCtD
Sumatriptan—Discomfort—Methotrexate—testicular cancer	9.79e-05	0.000376	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—testicular cancer	9.79e-05	0.000376	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—testicular cancer	9.77e-05	0.000375	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—testicular cancer	9.75e-05	0.000375	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—testicular cancer	9.69e-05	0.000372	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—testicular cancer	9.63e-05	0.00037	CcSEcCtD
Sumatriptan—Confusional state—Methotrexate—testicular cancer	9.58e-05	0.000368	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—testicular cancer	9.57e-05	0.000368	CcSEcCtD
Sumatriptan—Cough—Epirubicin—testicular cancer	9.5e-05	0.000365	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methotrexate—testicular cancer	9.5e-05	0.000365	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—testicular cancer	9.44e-05	0.000363	CcSEcCtD
Sumatriptan—Infection—Methotrexate—testicular cancer	9.44e-05	0.000363	CcSEcCtD
Sumatriptan—Nausea—Etoposide—testicular cancer	9.42e-05	0.000362	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—testicular cancer	9.4e-05	0.000361	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—testicular cancer	9.35e-05	0.000359	CcSEcCtD
Sumatriptan—Nervous system disorder—Methotrexate—testicular cancer	9.32e-05	0.000358	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—testicular cancer	9.31e-05	0.000358	CcSEcCtD
Sumatriptan—Thrombocytopenia—Methotrexate—testicular cancer	9.3e-05	0.000357	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—testicular cancer	9.27e-05	0.000356	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—testicular cancer	9.27e-05	0.000356	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—testicular cancer	9.27e-05	0.000356	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—testicular cancer	9.26e-05	0.000356	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—testicular cancer	9.24e-05	0.000355	CcSEcCtD
Sumatriptan—Skin disorder—Methotrexate—testicular cancer	9.23e-05	0.000355	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methotrexate—testicular cancer	9.18e-05	0.000353	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—testicular cancer	9.16e-05	0.000352	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—testicular cancer	9.09e-05	0.000349	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—testicular cancer	9.07e-05	0.000349	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—testicular cancer	9.05e-05	0.000348	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—testicular cancer	9.04e-05	0.000347	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—testicular cancer	8.96e-05	0.000344	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—testicular cancer	8.91e-05	0.000342	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—testicular cancer	8.89e-05	0.000342	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—testicular cancer	8.89e-05	0.000342	CcSEcCtD
Sumatriptan—Hypotension—Methotrexate—testicular cancer	8.88e-05	0.000341	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—testicular cancer	8.86e-05	0.00034	CcSEcCtD
Sumatriptan—Infection—Epirubicin—testicular cancer	8.83e-05	0.000339	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—testicular cancer	8.79e-05	0.000338	CcSEcCtD
Sumatriptan—Shock—Epirubicin—testicular cancer	8.75e-05	0.000336	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—testicular cancer	8.73e-05	0.000336	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—testicular cancer	8.72e-05	0.000335	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—testicular cancer	8.7e-05	0.000334	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—testicular cancer	8.7e-05	0.000334	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—testicular cancer	8.68e-05	0.000333	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methotrexate—testicular cancer	8.65e-05	0.000333	CcSEcCtD
Sumatriptan—Skin disorder—Epirubicin—testicular cancer	8.63e-05	0.000332	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—testicular cancer	8.59e-05	0.00033	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—testicular cancer	8.58e-05	0.00033	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—testicular cancer	8.58e-05	0.00033	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—testicular cancer	8.58e-05	0.00033	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—testicular cancer	8.55e-05	0.000329	CcSEcCtD
Sumatriptan—Paraesthesia—Methotrexate—testicular cancer	8.53e-05	0.000328	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—testicular cancer	8.48e-05	0.000326	CcSEcCtD
Sumatriptan—Dyspnoea—Methotrexate—testicular cancer	8.47e-05	0.000325	CcSEcCtD
Sumatriptan—Somnolence—Methotrexate—testicular cancer	8.44e-05	0.000325	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—testicular cancer	8.39e-05	0.000322	CcSEcCtD
Sumatriptan—Hypotension—Epirubicin—testicular cancer	8.31e-05	0.000319	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—testicular cancer	8.29e-05	0.000319	CcSEcCtD
Sumatriptan—Decreased appetite—Methotrexate—testicular cancer	8.26e-05	0.000317	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—testicular cancer	8.23e-05	0.000316	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—testicular cancer	8.23e-05	0.000316	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Methotrexate—testicular cancer	8.2e-05	0.000315	CcSEcCtD
Sumatriptan—Fatigue—Methotrexate—testicular cancer	8.19e-05	0.000315	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—testicular cancer	8.17e-05	0.000314	CcSEcCtD
Sumatriptan—Pain—Methotrexate—testicular cancer	8.12e-05	0.000312	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—testicular cancer	8.1e-05	0.000311	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—testicular cancer	8.09e-05	0.000311	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—testicular cancer	8.07e-05	0.00031	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—testicular cancer	8.05e-05	0.000309	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—testicular cancer	8.03e-05	0.000309	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—testicular cancer	7.99e-05	0.000307	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—testicular cancer	7.98e-05	0.000307	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—testicular cancer	7.95e-05	0.000306	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—testicular cancer	7.93e-05	0.000305	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—testicular cancer	7.9e-05	0.000304	CcSEcCtD
Sumatriptan—Feeling abnormal—Methotrexate—testicular cancer	7.83e-05	0.000301	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Methotrexate—testicular cancer	7.77e-05	0.000299	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—testicular cancer	7.73e-05	0.000297	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—testicular cancer	7.69e-05	0.000295	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—testicular cancer	7.67e-05	0.000295	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—testicular cancer	7.66e-05	0.000295	CcSEcCtD
Sumatriptan—Pain—Epirubicin—testicular cancer	7.6e-05	0.000292	CcSEcCtD
Sumatriptan—Constipation—Epirubicin—testicular cancer	7.6e-05	0.000292	CcSEcCtD
Sumatriptan—Urticaria—Methotrexate—testicular cancer	7.55e-05	0.00029	CcSEcCtD
Sumatriptan—Abdominal pain—Methotrexate—testicular cancer	7.51e-05	0.000289	CcSEcCtD
Sumatriptan—Body temperature increased—Methotrexate—testicular cancer	7.51e-05	0.000289	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	7.49e-05	0.000288	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—testicular cancer	7.39e-05	0.000284	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—testicular cancer	7.33e-05	0.000282	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—testicular cancer	7.33e-05	0.000282	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—testicular cancer	7.31e-05	0.000281	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—testicular cancer	7.27e-05	0.000279	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—testicular cancer	7.15e-05	0.000275	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—testicular cancer	7.1e-05	0.000273	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—testicular cancer	7.09e-05	0.000273	CcSEcCtD
Sumatriptan—Urticaria—Epirubicin—testicular cancer	7.06e-05	0.000271	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—testicular cancer	7.03e-05	0.00027	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—testicular cancer	7.03e-05	0.00027	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—testicular cancer	7.03e-05	0.00027	CcSEcCtD
Sumatriptan—Abdominal pain—Epirubicin—testicular cancer	7.03e-05	0.00027	CcSEcCtD
Sumatriptan—Hypersensitivity—Methotrexate—testicular cancer	7e-05	0.000269	CcSEcCtD
Sumatriptan—Asthenia—Methotrexate—testicular cancer	6.82e-05	0.000262	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—testicular cancer	6.78e-05	0.00026	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—testicular cancer	6.73e-05	0.000258	CcSEcCtD
Sumatriptan—Pruritus—Methotrexate—testicular cancer	6.72e-05	0.000258	CcSEcCtD
Sumatriptan—Hypersensitivity—Epirubicin—testicular cancer	6.55e-05	0.000252	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—testicular cancer	6.53e-05	0.000251	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—testicular cancer	6.5e-05	0.00025	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—testicular cancer	6.5e-05	0.00025	CcSEcCtD
Sumatriptan—Diarrhoea—Methotrexate—testicular cancer	6.5e-05	0.00025	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—testicular cancer	6.38e-05	0.000245	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—testicular cancer	6.29e-05	0.000242	CcSEcCtD
Sumatriptan—Dizziness—Methotrexate—testicular cancer	6.28e-05	0.000241	CcSEcCtD
Sumatriptan—Diarrhoea—Epirubicin—testicular cancer	6.08e-05	0.000234	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—testicular cancer	6.06e-05	0.000233	CcSEcCtD
Sumatriptan—Vomiting—Methotrexate—testicular cancer	6.04e-05	0.000232	CcSEcCtD
Sumatriptan—Rash—Methotrexate—testicular cancer	5.99e-05	0.00023	CcSEcCtD
Sumatriptan—Dermatitis—Methotrexate—testicular cancer	5.98e-05	0.00023	CcSEcCtD
Sumatriptan—Headache—Methotrexate—testicular cancer	5.95e-05	0.000229	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—testicular cancer	5.9e-05	0.000227	CcSEcCtD
Sumatriptan—Dizziness—Epirubicin—testicular cancer	5.88e-05	0.000226	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—testicular cancer	5.82e-05	0.000224	CcSEcCtD
Sumatriptan—Vomiting—Epirubicin—testicular cancer	5.65e-05	0.000217	CcSEcCtD
Sumatriptan—Nausea—Methotrexate—testicular cancer	5.64e-05	0.000217	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—testicular cancer	5.63e-05	0.000216	CcSEcCtD
Sumatriptan—Rash—Epirubicin—testicular cancer	5.6e-05	0.000215	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—testicular cancer	5.6e-05	0.000215	CcSEcCtD
Sumatriptan—Headache—Epirubicin—testicular cancer	5.57e-05	0.000214	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—testicular cancer	5.44e-05	0.000209	CcSEcCtD
Sumatriptan—Nausea—Epirubicin—testicular cancer	5.28e-05	0.000203	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—testicular cancer	5.23e-05	0.000201	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—testicular cancer	5.19e-05	0.000199	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—testicular cancer	5.18e-05	0.000199	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—testicular cancer	5.15e-05	0.000198	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—testicular cancer	4.89e-05	0.000188	CcSEcCtD
